Why the study?
Does a modified PT assay with added calcium chloride improve the dynamic range and sensitivity for assessing the anticoagulant activity of oral factor Xa inhibitors?
Does a modified PT assay with added calcium chloride improve the dynamic range and sensitivity for assessing the anticoagulant activity of oral factor Xa inhibitors?
Adding calcium chloride to the thromboplastin reagent in a modified PT assay improves its dynamic range and sensitivity, making it a viable pharmacodynamic marker for oral factor Xa inhibitors.
Answers are grounded in this paper and cite their sources.
May support modified PT assay development for factor Xa inhibitors in animals; leaves open human translation and clinical adoption.
Conventional prothrombin time (PT) assays have limited sensitivity and dynamic range in monitoring the anticoagulant activity of direct factor Xa inhibitors. Hence, new assays are needed. We modified a PT assay by adding calcium chloride (CaCl 2 ) to the thromboplastin reagent to increase assay dynamic range and improve sensitivity. Effects of calcium and sodium ion concentrations, and sample handling, were evaluated to optimize assay performance. Increasing concentrations of calcium ions produced progressive increases in PT across the factor Xa inhibitor concentrations of 0 to 2500 nmol/L for razaxaban and apixaban. The greatest effect was seen when the thromboplastin reagent was diluted 1:2.25 with 100 mmol/L CaCl 2 (thus selected for routine use). The optimized assay showed an interassay precision of 1.5 to 9.3 percentage coefficient of variation (%CV) for razaxaban and 3.1 to 4.6 %CV for apixaban. We conclude that the modified PT assay is likely to be suitable as a pharmacodynamic marker for activity at therapeutic concentrations of factor Xa inhibitors.
No takes yet. Share an insight, caveat, or question.
Barrett et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: